Table 1 Baseline demographic and clinical characteristics for Routine F/U and Home F/U patients according to randomization group in the original RCT

Demographic

Age, mean years (SD)

65.2 (9.3)

65.2 (10.1)

65.3 (8.4)

67.7 (9.5)

70.0 (9.5)

65.9 (9.3)

75 years and older

13.9

16.5

11.1

29.5

40.7

20.6

Male

78.6

78.3

78.9

83.6

78.8

88.2

Caucasian

95.6

94.6

96.6

98.3

96.3

100

College education or higher

48.4

50.5

46.0

44.8

41.7

47.1

Married

73.3

73.2

73.3

77.0

63.0

88.2*

Cardiac and Neurologic History

Cardiac symptom duration, mean years (SD)

5.0 (7.1)

5.3 (7.6)

4.7 (6.7)

5.7 (8.6)

5.6 (8.4)

5.9 (8.8)

Current and former smokers

72.7

71.1

74.4

78.7

81.5

76.5

Canadian cardiovascular class

  I

18.7

19.6

17.8

13.1

14.8

11.8

  II

22.5

24.7

20.0

27.9

25.9

29.4

  III

12.3

11.3

13.3

16.4

29.6

5.9

  IV

27.8

30.9

24.4

16.4

14.8

17.7

Ejection Fraction, mean (SD)

48.5 (12.1)

49.3 (12.1)

47.6 (12.2)

47.4 (13.9)

47.2 (15.1)

47.6 (13.0)

Left main disease

13.9

14.4

13.3

11.5

22.2

2.9*

Previous MI

42.3

36.1

48.9

44.3

44.4

44.1

Congestive heart failure

10.7

10.3

11.1

11.5

14.8

8.8

COPD/Asthma

10.7

6.2

15.6*

6.6

7.4

5.8

Peripheral vascular disease

21.9

23.7

20.0

16.4

22.2

11.8

CVA

11.8

8.3

15.6

8.2

7.4

8.8

Charlson Comorbidity Score

  0-1

58.8

58.8

58.9

54.1

48.1

58.8

  2-3

27.8

27.8

27.8

36.1

44.4

29.4

  ≥ 4

13.4

13.4

13.3

9.8

7.4

11.8

Hypertension

49.2

43.3

55.6

59.0

59.3

58.8

Dialysis

1.6

2.1

1.1

0

0

0

Renal dysfunction

5.9

6.2

5.6

4.9

3.7

5.9

Diabetes

20.3

23.7

16.7

19.7

18.5

20.6

  End organ damage

44.7

43.5

46.7

33.3

40.0

28.6

Medications

Diuretics

16.0

16.5

15.6

27.9

33.3

23.5

Calcium channel blockers

62.6

60.8

64.4

63.9

55.6

70.6

Nitrates

55.1

60.8

48.9

52.5

70.4

38.2*

Beta blockers

57.8

55.7

60.0

52.5

48.2

55.9

Ace inhibitors

16.6

17.5

15.6

16.4

22.2

11.8

Neurocognitive tests

Ammons IQ Test, mean (SD)

106.6 (14.4)

107.2 (15.5)

106.0 (13.3)

102.3 (12.2)

100.2 (10.5)

103.9 (13.2)

Linguistic Function

  Boston Naming Test, median (range)

26.0 (8–30)

26.0 (8–30)

26.0 (11–30)

25 (9–30)

25 (12–30)

25 (9–30)

  Controlled Word Association, mean (SD)

38.4 (13.4)

38.4 (13.5)

38.4 (13.3)

35.1(12.6)

34.2 (11.4)

35.7 (13.5)

Memory

  Benton Visual Recall, mean (SD)

5.2 (2.2)

5.3 (2.1)

5.1 (2.3)

4.6 (2.2)

5.0 (1.9)

4.3 (2.4)

  Benton Recognition, median (range)

8 (3–10)

8 (3–10)

8 (4–10)

7.5 (0–10)

7 (3–10)

8 (0–10)

  Mattis-Kovner Recall, mean (SD)

10.7 (3.4)

10.9 (3.4)

10.6 (3.4)

9.9 (3.6)

9.6 (4.0)

10.3 (3.2)

  Mattis-Kovner, mean (SD)

2.7 (0–3.9)

2.7 (0–3.9)

2.7 (0–3.9)

2.6 (1.2-3.9)

2.4 (1.3-3.9)

2.7 (1.2-3.9)

  Recognition, median (range)

Psychomotor function

  Trails A, median (range)

40 (15–162)

38.5 (15–162)

41 (20–141)

39 (17–217)

39 (19–100)

41.5 (17–217)

  Trails B, median (range)

86 (32–350)

85.0 (32–350)

89.5 (42–320)

104.5 (38–405)

117 (42–405)

92 (38–309)

  Digit Symbol, mean (SD)

42.1 (12.3)

42.7 (13.6)

41.5 (10.7)

38.2 (11.9)

34.7 (12.3)

41.2 (10.9)*

  Digit Span, mean (SD)

14.7 (4.1)

15.2 (4.0)

14.1 (4.1)

14.0 (3.7)

13.3 (3.5)

14.5 (3.8)

  Finger Tapping Dominant, mean (SD)

47.1 (10.6)

47.0 (10.6)

47.2 (10.6)

44.2 (8.4)

45.0 (8.9)

43.5 (8.1)

  Finger Tapping Non-dominant, mean (SD)

42.5 (8.9)

42.1 (9.2)

43.1 (8.7)

40.7 (8.1)

42.0 (8.0)

39.6 (8.2)